Capital International Investors Novo Cure LTD Transaction History
Capital International Investors
- $511 Billion
- Q4 2024
A detailed history of Capital International Investors transactions in Novo Cure LTD stock. As of the latest transaction made, Capital International Investors holds 8,873,902 shares of NVCR stock, worth $172 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
8,873,902
Previous 7,922,761
12.01%
Holding current value
$172 Million
Previous $124 Million
113.55%
% of portfolio
0.05%
Previous 0.02%
Shares
23 transactions
Others Institutions Holding NVCR
# of Institutions
290Shares Held
75.6MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$235 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$228 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$93.2 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$53 Million5.68% of portfolio
-
State Street Corp Boston, MA2.64MShares$51.1 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.03B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...